General Medicine

Latest News

Dexamethasone

Study Compares Baricitinib to Dexamethasone for COVID-19

For hospitalized patients with COVID-19 requiring supplemental oxygen, baricitinib plus remdesivir and dexamethasone plus remdesivir result in similar mechanical ventilation-free survival by day 29, but adverse events occur more frequently with dexamethasone.
Next post in General Medicine